Who owns VYNE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Vyne Therapeutics stock

Who bought or sold VYNE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cormorant Asset Management 1.4M $2.6M 0% Sep 2024
 View chart
Eventide Asset Management 1.4M $3.1M 0% Sep 2024
 View chart
Citadel Advisors 1.2M $2.2M -2% Sep 2024
 View chart
DSC Advisors 697k $1.3M 0% Sep 2024
 View chart
Palo Alto Investors 445k $837k 0% Sep 2024
 View chart
Vanguard Group 444k $834k 0% Sep 2024
 View chart
Exome Asset Management 353k $665k 0% Sep 2024
 View chart
Parkman Healthcare Partners 203k $382k -41% Sep 2024
 View chart
Schonfeld Strategic Advisors 169k $317k -22% Sep 2024
 View chart
ADAR1 Capital Management 153k $287k -11% Sep 2024
 View chart
Geode Capital Management 135k $253k -1% Sep 2024
 View chart
Renaissance Technologies 87k $163k 37% Sep 2024
 View chart
BlackRock 83k $279k 0% Dec 2024
 View chart
Silverarc Capital Management 77k $144k -84% Sep 2024
 View chart
Springbok Capital Management 65k $123k 0% Sep 2024
 View chart
Susquehanna International 60k $114k 0% Sep 2024
 View chart
Northern Trust 37k $70k 100% Sep 2024
 View chart
XTX Topco 21k $70k 100% Dec 2024
 View chart
Commonwealth Equity Services 18k $61k 0% Dec 2024
 View chart
Lynx1 Capital Management 16k $30k 0% Sep 2024
 View chart
State Street Corporation 16k $30k 0% Sep 2024
 View chart
BFSG 3.5k $12k 100% Dec 2024
 View chart
Royal Bank of Canada 2.4k $5.0k -45% Sep 2024
 View chart
Bank of America Corporation 2.3k $4.3k -1% Sep 2024
 View chart
Tower Research Capital 1.4k $4.6k -37% Dec 2024
 View chart
Centerpoint Advisors 350.00 $999.985000 0% Dec 2024
 View chart
Russell Investments 187.00 $350.999000 0% Sep 2024
 View chart
Jpmorgan Chase & Co 177.00 $332.193600 1% Sep 2024
 View chart
Barclays 100.00 $0 100% Sep 2024
 View chart
Wells Fargo & Company 65.00 $121.998500 0% Sep 2024
 View chart
UBS Group 14.00 $25.999400 -100% Sep 2024
 View chart

Who sold out of Vyne Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
AlphaCentric Advisors Sep 2024 269k $505k